A clinical trial has resulted in the first approval of a treatment for advanced alveolar soft part sarcoma (ASPS). The immunotherapy drug atezolizumab (Tecentriq) was recently approved by the U.S.

Please provide your email address to receive an email when new articles are posted on . Atezolizumab monotherapy induced objective responses in more than one-third of patients. No treatment-related ...

Credit: Thinkstock. The approval was based on data from a phase 2 study that included 49 patients with unresectable or metastatic ASPS. The Food and Drug Administration (FDA) has approved Tecentriq ...

A clinical trial led by the National Cancer Institute (NCI), part of the National Institutes of Health, has resulted in the first approval of a treatment for advanced alveolar soft part sarcoma (ASPS) ...

The positions in the table below reflect the Cure Alveolar Soft Part Sarcoma International's position overall, domestically, within their sector, and in various subject areas based on their Share.

A retrospective study of anlotinib combined with adriamycin and ifosfamide in unresectable soft tissue sarcoma. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does ...

Using Recentin (cediranib) can help stabilize disease in patients with alveolar soft-part sarcoma, a rare sarcoma subset. The use of Recentin (cediranib) can play an important role in long-term ...

Safety and efficacy of letetresgene autoleucel (lete-cel; GSK3377794) in advanced myxoid/round cell liposarcoma (MRCLS) following high lymphodepletion (Cohort 2): Interim analysis. This is an ASCO ...

Kyoto, Japan -- Cancer, the second leading cause of death worldwide, is more likely to respond to effective treatment if identified early before metastasizing, resulting in a greater probability of ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved atezolizumab for adults and children aged 2 years or older with unresectable or metastatic ...

Cancer, the second leading cause of death worldwide, is more likely to respond to effective treatment if identified early before metastasizing, resulting in a greater probability of surviving. Science ...